Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Neoantigen-directed immune escape in lung cancer evolution

Open access

Abstract

The interplay between an evolving cancer and a dynamic immune microenvironment remains unclear. Here we analyse 258 regions from 88 early-stage, untreated non-small-cell lung cancers using RNA sequencing and histopathology-assessed tumour-infiltrating lymphocyte estimates. Immune infiltration varied both between and within tumours, with different mechanisms of neoantigen presentation dysfunction enriched in distinct immune microenvironments. Sparsely infiltrated tumours exhibited a waning of neoantigen editing during tumour evolution, indicative of historical immune editing, or copy-number loss of previously clonal neoantigens. Immune-infiltrated tumour regions exhibited ongoing immunoediting, with either loss of heterozygosity in human leukocyte antigens or depletion of expressed neoantigens. We identified promoter hypermethylation of genes that contain neoantigenic mutations as an epigenetic mechanism of immunoediting. Our results suggest that the immune microenvironment exerts a strong selection pressure in early-stage, untreated non-small-cell lung cancers that produces multiple routes to immune evasion, which are clinically relevant and forecast poor disease-free survival.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-019-1032-7

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 946

Metadata

Authors
The TRACERx consortium, Rosenthal, R., Cadieux, E. L., Salgado, R., Bakir, M. A., Moore, D. A., Hiley, C. T., Lund, T., Tanić, M., Reading, J. L., Joshi, K., Henry, J. Y., Ghorani, E., Wilson, G. A., Birkbak, N. J., Jamal-Hanjani, M., Veeriah, S., Szallasi, Z., Loi, S., Hellmann, M. D., Feber, A., Chain, B., Herrero, J., Quezada, S. A., Demeulemeester, J., Van Loo, P., Beck, S., McGranahan, N., & Swanton, C.
Affiliations
  • The Francis Crick Institute (GB)
  • The University of Melbourne (AU)
  • University College London (GB)
  • Cancer Research UK (GB)
  • Memorial Sloan Kettering Cancer Center (US)
Corresponding author
  • McGranahan, Nicholas
  • Swanton, Charles
Venue
Nature
Published
2019-03
Volume
567
Issue
7749
Pages
479-485
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2924359886
Cited by
946
References
35
Citations by year
2026: 81 · 2025: 95 · 2024: 117 · 2023: 139 · 2022: 152 · 2021: 178 · 2020: 117 · 2019: 66
FWCI
54.65
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • PubMed Central (acceptedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Lirias (KU Leuven) (submittedVersion)
Funders
  • Wellcome Trust (FC001202, FC001169, 107963/Z/15/Z, 211179/Z/18/Z)
  • Francis Crick Institute (10169, 10002, 10233, 10202)
  • Cancer Research UK (19278, 23896, 24314, 20466, A22246, A20764, 16463, 24956, 20764, S_3441, 21999, 28990, 17786, 22246, 20265, 29420, 20465, 29569, 30025)
  • National Institute for Health and Care Research (CL-2015-17-002, CL-2015-18-009, ACF-2014-18-006)
  • Royal Society
  • Rosetrees Trust
  • Novo Nordisk Fonden (NNF15OC0016584)
  • National Cancer Institute (P30CA008748)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
neoantigens, immune evasion, non-small cell lung cancer, tumor immune microenvironment, tumor-infiltrating lymphocytes, immunoediting, loss of heterozygosity, HLA loss, copy number loss, promoter hypermethylation, tumor evolution, disease-free survival
MeSH terms
Adenocarcinoma, Antigens, Neoplasm, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Female, Humans, Lung Neoplasms, Male, Prognosis, Gene Expression Regulation, Neoplastic, Lymphocytes, Tumor-Infiltrating, Antigen Presentation, Disease-Free Survival, Tumor Escape, Evolution, Molecular, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neoantigen-directed immune escape in lung cancer evolution. https://app.cochat.ai/papers/10.1038/s41586-019-1032-7
The paper
The TRACERx consortium, Rosenthal, R., Cadieux, E. L., Salgado, R., Bakir, M. A., Moore, D. A., Hiley, C. T., Lund, T., Tanić, M., Reading, J. L., Joshi, K., Henry, J. Y., Ghorani, E., Wilson, G. A., Birkbak, N. J., Jamal-Hanjani, M., Veeriah, S., Szallasi, Z., Loi, S., . . . Swanton, C. (2019). Neoantigen-directed immune escape in lung cancer evolution. Nature. https://doi.org/10.1038/s41586-019-1032-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.